SAN MATEO, Calif., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic ...

Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license partner Ascletis Ascletis ...

(MENAFN- GlobeNewsWire - Nasdaq) Denifanstat met all primary and secondary endpoints versus placebo and was generally well tolerated in a Phase 3 clinical trial in acne in China conducted by license ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...

Mike Shildt is retiring as San Diego Padres manager with two years remaining on his contract, saying "the grind of the baseball season has taken a severe toll on me mentally, physically and ...

EDGEWATER, Fla. — Severe storms triggered flash flooding in parts of Volusia County on Friday. Several streets and homes were flooding in parts of Edgewater and New Smyrna Beach. Channel 9 has several ...

Friday will be a comfortable day with some strong winds moving through, but severe storms will pop up overnight Saturday into Sunday. Friday will be sunny and 77 degrees with southwest winds gusting ...

・The trial was conducted by Sagimet’s license partner for China, Ascletis Bioscience Co., in 480 patients with moderate to severe acne vulgaris. ・The company said that once daily oral 50 mg ...

If you purchase an independently reviewed product or service through a link on our website, SheKnows may receive an affiliate commission. I don’t know who needs to hear this, but Halloween is less ...

Considering the uncharacteristically sloppy last two games, it feels like a good time for the Buffalo Bills' Bye. Factoring in head coach Sean McDermott's record coming off a week's rest, it's ...